Navigation Links
New Treatment For Obstructive Sleep Apnea Now Available In Canada
Date:11/19/2012

SAN JOSE, Calif. and TORONTO, Nov. 19, 2012 /PRNewswire/ -- Ventus Medical is pleased to announce the introduction of its proprietary Provent® Sleep Apnea Therapy into Canada. Provent Therapy is an innovative, non-invasive treatment for obstructive sleep apnea (OSA). Provent Therapy is now available in the province of Ontario and will be available throughout Canada by June 2013. ioSleep, Inc. is the strategic distribution partner of Provent Therapy in Canada.

(Photo: http://photos.prnewswire.com/prnh/20121119/SF15670)

(Logo: http://photos.prnewswire.com/prnh/20120712/LA37941LOGO)

There is growing demand for clinically proven sleep apnea treatments and the introduction of Provent represents a scientifically validated, innovative and user-friendly approach. Provent works across mild, moderate, and severe OSA and utilizes nasal expiratory positive airway pressure (EPAP) to keep a patient's airway open during sleep.

"According to the Public Health Agency of Canada over 1 in 4 Canadian adults are at high risk of having OSA.  OSA is suspected in patients who are loud snorers, excessively sleepy, obese and hypertensive," said Dr. John Fleetham, Professor of Medicine at the University of British Columbia. "OSA is increasingly being recognised in Canadian patients.  CPAP (continuous positive airway pressure) is the primary treatment for OSA, however not all patients can tolerate it as a long term treatment." Dr. Fleetham further comments, "I welcome new validated treatment alternatives for OSA such as Provent Sleep Apnea Therapy."

"We believe clinically-proven Provent Therapy offers a unique and convenient alternative to CPAP treatment for the large number of people in Canada currently affected by OSA," said Philip Westbrook, M.D., chief medical officer of Ventus Medical. "Prove
'/>"/>

SOURCE Ventus Medical
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... CARLSBAD, Calif. , May 4, 2015  Isis ... an exclusive license agreement with Bayer HealthCare (Bayer) to ... of thrombosis. Under the terms of the agreement, Isis ... near-term payments, including an immediate $100 million up-front payment ... program following a Phase 2 study in patients with ...
(Date:5/4/2015)... NEW YORK , May 4, 2015  FireflySci Inc., the newest member of the ... months after launch, they have turned the cuvette industry on its head by offering scientists amazing ... http://photos.prnewswire.com/prnh/20150501/213243LOGO Photo - http://photos.prnewswire.com/prnh/20150501/213244 ... ... ...
(Date:5/4/2015)... 2015 Intarcia Therapeutics, Inc. ... into the newly created role of Chief ... pharmaceutical executive with world-class experience – most recently ... service at industry leaders such as Pfizer and ... range of therapeutic areas, including: cardiovascular, metabolic, oncology, ...
Breaking Medicine Technology:Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4
(Date:5/4/2015)... In response to the proposed mammography ... (USPSTF), Strategic Radiology® (SR®) fully aligns itself with ... Gynecologists (ACOG), the American College Of Surgeons, Susan ... (ACS), American College of Radiology (ACR), and Society ... screening mammography for women beginning at age 40 ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 For partners ... brand new lubricant -- Astroglide TTC™ (Trying to ... motility and alter pH levels, Astroglide TTC™ is specially ... , According to the Centers for Disease Control, an ... trouble getting pregnant or sustaining a pregnancy, and over ...
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 Fast ... Eric Gladen’s documentary Trace Amounts, and Allison Folmar, JD, ... autism conference held internationally. , On Sunday, May 24, ... recovery from autism possible?" Are you interested in Ryan ... In There: winning our war against autism was ...
(Date:5/4/2015)... 2015 “St. Louis has long represented ... the West,” so it is the perfect place for ... Dr. Ben Litalien, Chief Development Officer for Zerorez. ... and will provide veterans with a $10,000 discount on ... to have a number of Military Veterans in its ...
(Date:5/3/2015)... 2015 AvePoint, the ... and devices, today announced it is a Platinum ... (IAPP) Asia Privacy Forum, taking place May 5-6, ... event, AvePoint will showcase its compliance, risk, and ... , Visit AvePoint for New Solutions , ...
Breaking Medicine News(10 mins):Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 4
... an Increase in the, Number of Patients Treated for Low ... Surveyed MCOs Will Not Add Novel HDL Drugs to Their ... According to a New Report from Decision Resources, ... leading research and advisory firms for pharmaceutical and,healthcare issues, finds ...
... are concerned about access to care for seniors, and ... Medicare patients,according to a new public poll released today ... payments to physicians will be cut,10.6 percent, and over ... 40,percent while medical practice costs increase 20 percent., ...
... PITTSBURGH, March 19 To develop new strategies to ... of the worlds population and kills almost two million ... Vaccine Research has received an $11.4 million grant from ... enable Pitt researchers to use new imaging technologies to ...
... 19 Goosie, LLC announced today,that they will ... throughout the month of April with a series ... autistic children with special,discounts. Goosie is the market ... Cards are created online at http://www.goosiecards.com ...
... UMDNJ has received a grant for the UMDNJ-University Hospital ... Federation (IDF) BRIDGES program to tailor interventions to improve ... 2 diabetes. , The academic teaching hospital provides ... found that many of its patients never connect to ...
... follow a genetic program independent of developing tissue , , ... concept of how the brain,s blood supply develops is ... researchers. , In experiments with mice, the researchers found ... their own agenda beginning early in fetal development. They ...
Cached Medicine News:Health News:One-Third of U.S. Primary Care Physicians and Cardiologists Do Not Currently Prescribe Treatment to Meet HDL Cholesterol Targets as Recommended By National Guidelines 2Health News:One-Third of U.S. Primary Care Physicians and Cardiologists Do Not Currently Prescribe Treatment to Meet HDL Cholesterol Targets as Recommended By National Guidelines 3Health News:New Poll Shows Public Worried About Medicare Cuts Impact on Seniors, Boomers - Wants Congress To Act 2Health News:Stopping a deadly killer 2Health News:Goosie Cards to Support Autism Awareness Month With Special Discount Program 2Health News:International Diabetes Federation gives grant to UMDNJ-University Hospital in Newark 2Health News:International Diabetes Federation gives grant to UMDNJ-University Hospital in Newark 3Health News:Brain Blood Vessels Grow With Their Own Agenda 2
The Olympus full range of laparoscopes includes a range of diameters and directions of view -12 mm HDTV compatible model as well as a choice of 10 mm, 5 mm full screen and 3 mm....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Compact, economical Bactron II anaerobic environment system with air lock, workspace and a 200 plate capacity incubator delivers optimum productivity in a compact space....
This chamber is designed to provide a large workspace and gloveless dexterity in closed environment industrial, research and development, quality control packaging applications. Atmospheres of nitrog...
Medicine Products: